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Abstract
Background: Numerous papers have been published examining risk factors for revision of primary total hip
arthroplasty (THA), but there have been no comprehensive systematic literature reviews that summarize the most
recent findings across a broad range of potential predictors.
Methods: We performed a PubMed search for papers published between January, 2000 and November, 2010 that
provided data on risk factors for revision of primary THA. We collected data on revision for any reason, as well as on
revision for aseptic loosening, infection, or dislocation. For each risk factor that was examined in at least three
papers, we summarize the number and direction of statistically significant associations reported.
Results: Eighty-six papers were included in our review. Factors found to be associated with revision included
younger age, greater comorbidity, a diagnosis of avascular necrosis (AVN) as compared to osteoarthritis (OA), low
surgeon volume, and larger femoral head size. Male sex was associated with revision due to aseptic loosening and
infection. Longer operating time was associated with revision due to infection. Smaller femoral head size was
associated with revision due to dislocation.
Conclusions: This systematic review of literature published between 2000 and 2010 identified a range of
demographic, clinical, surgical, implant, and provider variables associated with the risk of revision following primary
THA. These findings can inform discussions between surgeons and patients relating to the risks and benefits of
undergoing total hip arthroplasty.
Keywords: Total hip arthroplasty, Revision, Failure, Risk factor, Aseptic loosening, Infection, Dislocation, Systematic
review
Background
Total hip arthroplasty (THA) is a highly successful and
cost-effective intervention for addressing pain and func-
tional deficits in patients with advanced hip disease [1-
3]. Although the results of THA are generally excellent,
some prostheses eventually fail. In many such cases, re-
vision surgery is performed. As a result, revision THA is
often used as a proxy for implant failure. In the US, over
50,000 revision THAs are performed every year at a dir-
ect cost exceeding $1 billion [4]. Due in part to contin-
ued growth in the utilization of primary THA, the
number of revisions may increase substantially in the
coming decades [5].
Long-term population-based studies have documented
rates of THA failure of 1% per year or less, though there
is considerable variation in revision rates among patient
groups defined by factors such as age and sex [6]. Identi-
fying risk factors for arthroplasty failure is challenging
because revision arthroplasty is a relatively infrequent
outcome that often occurs a decade or more after the
primary procedure. Thus, individual studies require large
sample sizes and/or lengthy follow-up periods to detect
statistically and clinically significant differences in the
risk of revision associated with purported risk factors.
Several articles have identified risk factors for revision of
primary THA based on data from registries or individual
centers, and these findings represent a potential wealth
of evidence on the effects of a range of risk factors on
revision of primary THA. However, a systematic review * Correspondence: jnkatz@partners.org
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and identify relevant trends.
Previous systematic reviews on risk factors for failure
of THA have typically focused on specific research ques-
tions such as the impact of anesthesia type, [7] under-
lying diagnosis, [8] or cemented vs. uncemented fixation
[9]. A 2008 review by Santaguida et al. examined the ef-
fect of patient demographic factors on THA outcome
[10]. That review focused on studies published between
1980 and 2001, however, thereby excluding more re-
cently published work that incorporates longer-term fol-
low-up and more contemporary processes of care such
as modern cementing techniques, biomaterials, and re-
habilitation approaches. To the best of our knowledge,
there have been no efforts to aggregate more recent data
on a more comprehensive set of risk factors.
The purpose of this systematic review is to summarize
the published literature on risk factors for revision of
primary THA relating to pre-operative patient demo-
graphic and clinical factors, surgical factors (including
features of the implant), and health care provider char-
acteristics. In addition to overall revision, we examine
risk factors for the three most common indications for
revision: aseptic loosening, infection, and dislocation,
each of which accounts for at least 15% of total revisions
[11-13]. This systematic review may help surgeons more
accurately assess the factors associated with failure of
THA, and may promote fully informed conversations
about the risks and benefits of the procedure between
surgeons and patients considering THA.
Methods
Search strategy
We conducted a PubMed search on November 16, 2010
to identify studies written in English published between
January 1, 2000 and November 1, 2010. We excluded
articles published prior to 2000 to ensure that the stud-
ies considered reflected secular changes that may have
taken place since the only previously published literature
synthesis [10]. We restricted the review to articles pub-
lished in peer-reviewed journals to ensure methodo-
logical oversight. We combined PubMed hip
arthroplasty MeSH Term keywords with search terms
relating to revision and failure risk to produce the fol-
lowing search query:
("Arthroplasty, Replacement, Hip*"[MeSH Major
Topic] OR (total[Title/Abstract] AND hip[Title/
Abstract] AND (arthroplasty[Title/Abstract] OR
replacement[Title/Abstract])) AND ("risk factor" OR
"risk of failure" OR "risk of revision" OR "rate of
failure" OR "rate of revision" OR "revision risk" OR
survival)
We performed three levels of screening to identify
papers for our review. We reviewed the titles in the
search results based on the exclusion criteria outlined in
Table 1. We retrieved and reviewed abstracts for all arti-
cles deemed potentially eligible at the title stage. Articles
that passed the abstract screening were retrieved as full
manuscripts for the final level of screening.
To ensure comparability across studies and generaliz-
ability, we excluded articles describing samples that
included less than 2,500 person-years of follow-up.
Given a revision risk of 1% per year, this criterion
ensures at least 25 ‘events’ (revisions) per study. Simi-
larly, we required a minimum of 25 cases in case–con-
trol studies.
Validation
A second reviewer independently screened random sam-
ples of 200 titles, 100 abstracts, and 40 papers. Any dis-
agreements in the decision of whether to exclude the
titles, abstracts, or papers were adjudicated by the senior
author (JNK). With the exception of one abstract, the se-
nior author’s assessment of exclusions on all screened
items agreed with that of the primary reviewer (JJZP) (the
abstract was found to be ineligible at the paper level).
We performed a second validation analysis on the over-
all screening process, determining agreement on a single
set of 200 papers that passed through all three levels of
screening (title, abstract, paper). Again, disagreements
were adjudicated by the senior author, and here too, the
senior author’s assessment concurred with that of the pri-
mary reviewer. Finally, the senior author abstracted key
data elements on eight eligible papers, blinded to the pri-
mary reviewer’s abstraction, and agreed with the primary
reviewer’s assessment on all elements in all eight papers.
Data abstraction
For articles that were eligible for inclusion, we extracted
information on study design, sample details, and average
follow-up time. We also abstracted data on the particu-
lar revision endpoint being studied (revision for any rea-
son, aseptic loosening, infection, or dislocation), the
specification of the risk factor being examined (e.g. age
dichotomized or defined as a continuous variable), the
effect measures (e.g. risk ratio, odds ratio, difference in
proportion), confidence intervals, and p-values. We
noted instances in which studies indicated in the text
that a particular factor was associated with a risk of revi-
sion and whether the association reached statistical sig-
nificance, even if no quantitative metric was provided.
Analysis
The heterogeneous nature of the studies’ follow-up
times, risk factor specifications, and effect measures pre-
cluded a formal meta-analysis. Instead, we identified all
risk factors that were examined by at least three studies
for a given endpoint and described the number and
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non-overlapping confidence intervals). We recognize
that categorizing studies on the basis of statistical signifi-
cance of the association of interest has many limitations.
For example, this approach does not incorporate the
magnitude of association, potential confounding, or
study quality. However, it does provide a common
framework with which each study can be assessed, pro-
viding a broad snapshot of the state of the literature.
The findings are intended to identify areas of discord-
ance, which should prompt closer examination of the lit-
erature, and of consistency, reflecting findings that
appear to be robust across multiple reports.
For some studies that did not include quantitative
results in the text, we were able to read results from sur-
vival curves presented in figures. In other cases, studies
collected data on risk factors but did not present them in
a format consistent with our analysis. For these papers,
we used the reported frequencies of exposure and revi-
sion to compute crude relative risk estimates, along with
95% confidence intervals and p-values. In two instances
[13,14], un-stratified frequencies were not reported in
the published paper, so we obtained the data from the
corresponding author. Statistical analyses were per-
formed using SAS software, Version 9.2 of the SAS Sys-
tem for Windows. (SAS Institute Inc., Cary, NC, USA.)
Results
Screening results
Full search results are represented in Figure 1. Of 2,122
titles identified by our search, we included 86 papers in
this review. Of those 86 papers, 65 examined risk factors
for revision for any reason, 30 examined risk factors for
aseptic loosening, nineteen for infection and twelve for
dislocation. In addition, three papers examined unique
endpoints: revision for acetabular osteolysis, revision
within 90 days of primary THA, and revision for any
reason other than infection (which conflates aseptic
loosening and dislocation). These papers were not
included in the analysis. The full abstraction of study de-
sign features and quantitative results on all 86 publica-
tions is available upon request. Frequencies for specific
risk factors by endpoint are presented in Table 2. Refer-
ence numbers for the papers examining each risk factor
for each endpoint are provided in Table 3.
We summarize the data on risk factors that were
examined in at least three papers for at least one end-
point in Table 4. Specifically, we indicate the number of
papers that found a statistically significant increased or
decreased risk and the number of papers that found no
significant association. Risk factors examined by at least
three papers for which no significant associations were
reported are not discussed in the text, but are included
in Table 4.
In order to present a consistent assessment, we
required at least three papers to address the same pair-
wise comparison to meet inclusion for Table 4. Several
underlying diagnoses met this threshold for at least one
comparison. Almost all of these comparisons used OA
as the reference group, so where possible, pairwise com-
parisons among the other diagnoses were performed
using the statistical method outlined above.
Revision for any reason
Demographic and clinical factors
Age Of the 26 papers [1,13-37] that examined age at
primary THA as a risk factor for revision for any reason,
Table 1 Exclusion criteria for the title, abstract, and paper-level screening of articles retrieved from the PubMed search
Exclusion criteria, listed in hierarchical order Example or explanation
￿ Focus on wrong procedure e.g. total knee arthroplasty
￿ Focus on risk factors for primary THA as opposed to risk of revision of THA
￿ Focus on outcomes of revision THA surgery as opposed to risk of revision of primary THA
￿ No living human subjects e.g. canine or simulation study
￿ Focus on non-standard THA e.g. hip resurfacing
￿ Focus on THA to address hip fracture as opposed to THA for hip arthritis
￿ Focus on non-prosthesis THA outcome e.g. mortality
￿ Focus on prosthesis-related non-revision outcome e.g. polyethylene wear
￿ Focus on stem or cup failure only* as opposed to revision of any component
￿ Focus on specific brand comparison only
+ no other comparisons reported
￿ Sample has less than 2,500 person-years at the title level, case studies were excluded
￿ Study includes no new clinical data* e.g. literature review
￿ Study does not report a comparative risk metric
+ e.g. no odds ratio or multiple survival curves
￿ Article could not be retrieved
+ not available in electronic or print archives
* Assessed at the abstract and paper levels of screening only.
+ Assessed at the paper level of screening only.
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with revision risk. Fifteen reported an increased risk of
revision for younger patients, irrespective of the particu-
lar age categories examined (categories ranged from ≤40
to ≥85). The risk of revision generally decreased per
additional decade of age. Two studies reported a statisti-
cally significant increased risk of revision for older
patients.
Sex Eight of the eighteen papers [13,18-22,27,29,31-
35,37,50-53] that evaluated the association of sex with
risk of revision reported a statistically significant associ-
ation. Seven reported an increased risk for men and one
study (6%) reported an increased risk of revision for
women.
Comorbidity (Charlson score) All five papers [27,29,
33-35] that examined comorbidities found a statistically
significant higher risk of revision for a higher Charlson
comorbidity score.
Underlying Diagnosis
Rheumatoid arthritis (RA) vs. osteoarthritis (OA) Of
the nine papers [13,21,27,37,47,61-64] that compared RA
and OA patients who underwent THA, three reported a
statistically significant increased revision risk for RA.
Avascular necrosis (AVN) vs. OA Eight papers
[13,14,18,27,47,53,61,65] compared patients with AVN
and OA, six of which reported a statistically significant
association. Five papers reported an increased risk for
AVN patients and one paper found a decreased risk for
AVN patients.
RA vs. AVN No statistically significant associations were
reported in the four papers [13,27,47,61] that compared
the revision risks in subjects with RA and AVN. Hailer
et al. [13] reported an increased risk for AVN patients in
their adjusted results, but we were unable to establish the
statistical significance of this comparison. The papers com-
paring RA with AVN did not indicate whether the cases of
AVN might have been accompanied by secondary OA.
Surgical and implant-related factors
Uncemented vs. cemented fixation Of the ten papers
[13,17,19,25,26,52,80-83] that considered uncemented
vs. cemented fixation, seven reported a statistically sig-
nificant association with revision risk. Five papers
reported a statistically significant increased risk for unce-
mented prostheses and two found a significant increased
risk of revision for cemented prostheses.
Hybrid vs. cemented fixation Four papers [25,26,52,82]
compared hybrid (cemented stem and uncemented cup)
and fully cemented fixation, and two of them found a
statistically significant increased risk of revision for hy-
brid THA.
Hybrid vs. uncemented fixation Of the four papers
[25,26,52,82] comparing hybrid (cemented stem and
uncemented cup) and fully uncemented fixation, three
papers reported a statistically significant association.
Two papers found an increased risk of revision for unce-
mented prostheses and one found an increased risk for
hybrid prostheses.
Femoral head size Two of the three papers [50,51,84]
examining femoral head size found a statistically
Figure 1 Manuscript search and selection process.
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Specific endpoint Revision (any) Aseptic loosening Infection Dislocation
Total for each endpoint* 65 30 19 12
Risk Factor N^ (%)
+ N (%) N (%) N (%)
Demographic Factors
Age 26 (40%) 12 (40%) 5 (26%) 4 (33%)
Sex 18 (28%) 10 (33%) 6 (32%) 2 (17%)
BMI/body weight 5 (8%) 2 (7%) 2 (11%) 1 (8%)
Race 1 (2%) — 1 (5%) —
Socioeconomic status 1 (2%) — 1 (5%) —
Tobacco use — 1 (3%) ——
Alcohol use —— 1 (5%) —
Preparation of living aids — 1 (3%) ——
Clinical Factors
Underlying diagnosis 21 (32%) 8 (27%) 6 (32%) 3 (25%)
Comorbidity (Charlson) 5 (8%) — 2 (11%) —
Diabetes 1 (2%) 1 (3%) 2 (11%) 1 (8%)
Medication use 3 (5%) 4 (13%) 3 (16%) 3 (25%)
Bilateral vs. unilateral THA 3 (5%) —— —
Genetic predisposition — 1 (3%) 2 (11%) —
Prior hip surgery 1 (2%) 1 (3%) 1 (5%) —
Post-THA childbirth 1 (2%) —— —
Surgical and Implant-Related Factors
Fixation 11 (17%) 6 (20%) 6 (32%) 2 (17%)
Femoral head size 3 (5%) 2 (7%) — 3 (25%)
Bearing 1 (2%) 1 (3%) — 1 (8%)
Coating 1 (2%) 1 (3%) ——
Femoral head material 1 (2%) —— —
Other design-related factors 1 (2%) 2 (7%) 1 (5%) —
Operating time 2 (3%) 1 (3%) 4 (21%) 2 (17%)
Surgical approach 1 (2%) 1 (3%) 1 (5%) 3 (25%)
Ventilation 1 (2%) — 2 (11%) —
Anesthesia —— 2 (11%) —
Infection prophylaxis 1 (2%) 1 (3%) 1 (5%) —
Fixation technique 1 (2%) 1 (3%) ——
Units blood transfused —— 1 (5%) —
Health Care Provider-Related Factors
Hospital volume 6 (9%) 1 (3%) ——
Hospital teaching status 2 (3%) — 1 (5%) —
Rural vs. urban hospital —— 1 (5%) —
Surgeon volume 4 (6%) —— —
Surgeon experience 2 (3%) —— —
* Papers that reported on multiple endpoints are included in each of the relevant columns.
^ — indicates no papers examined the risk factor for that endpoint.
+ Column percentages, not mutually exclusive.
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larger head size. In both studies, 28mm heads were the
largest head size examined.
Health care provider-related factors
Hospital volume Six papers [20,21,35,37,91,92] reported
on the association of hospital volume with revision. One
study found a statistically significant increased risk for
low-volume hospitals.
Surgeon volume Of the four papers [26,29,35,92] that
considered surgeon volume, three found a statistically
significant increased risk of revision for low-volume
surgeons.
Table 3 Reference numbers for papers examining each risk factor for each endpoint
Risk factor Reference numbers for papers
Revision (any) Aseptic loosening Infection Dislocation
Demographic Factors
Age [1,13-37][ 1,13,16,17,19,20,28,38-42][ 13,43-46][ 26,47-49]
Sex [13,18-22,27,29,31-35,37,50-53][ 1,13,17,19,20,28,38,40-42][ 13,43-46,54][ 47,48]
BMI/body weight [55-59][ 39,55][ 44,57][ 57]
Race [34] — [45] —
Socioeconomic status [15] — [45] —
Tobacco use — [60] ——
Alcohol use —— [44] —
Preparation of living aids — [40] ——
Clinical Factors
Underlying diagnosis [13,14,16,18,21,27,31,35,37,47,51,53,61-69][ 1,13,16,28,38,40,64,69][ 13,43,44,46,54,61][ 47,48,61]
Comorbidity (Charlson) [27,29,33-35] — [45,70] —
Diabetes [70][ 70][ 44,70][ 70]
Medication use [68,71,72][ 60,68,71,72][ 68,71,72][ 68,71,72]
Bilateral vs. unilateral THA [73-75] —— —
Genetic predisposition — [76][ 77,78] —
Prior hip surgery [18][ 28][ 46] —
Post-THA childbirth [79] —— —
Surgical and Implant-Related Factors
Fixation [13,17,19,25,26,52,61,80-83][ 13,17,19,81-83][ 13,26,43,46,81,83][ 47,83]
Femoral head size [50,51,84][ 41,42] — [47-49]
Bearing [85][ 86] — [49]
Coating [19][ 19] ——
Femoral head material [51] —— —
Other design-related factors [87][ 87,88][ 43] —
Operating time [33,83][ 83][ 43,45,46,83][ 48,83]
Surgical approach [11][ 11][ 11][ 11,26,48]
Ventilation [89] — [43,46] —
Anesthesia —— [44,46] —
Infection prophylaxis [89][ 89][ 89] —
Fixation technique [90][ 90] ——
Units blood transfused —— [44] —
Health Care Provider-Related Factors
Hospital volume [20,21,35,37,91,92][ 20] ——
Hospital teaching status [21,35] — [45] —
Rural vs. urban hospital —— [45] —
Surgeon volume [26,29,35,92] —— —
Surgeon experience [21,93] —— —
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 6 of 13
http://www.biomedcentral.com/1471-2474/13/251Revision for aseptic loosening
Demographic and Clinical Factors
Age Of the twelve papers [1,13,16,17,19,20,28,55-59]
that evaluated the association of age at primary THA
with the risk of revision for aseptic loosening, eight
papers reported a statistically significant increased risk
for younger patients. While these studies used different
age stratifications, they consistently found higher risk in
younger patients.
Sex Ten papers [1,13,17,19,20,28,55,57-59] considered
the association of sex with revision for aseptic loosening,
and six papers reported a statistically significant associ-
ation. Five papers reported an increased risk for men and
one paper found an increased risk for women.
Underlying diagnosis
RA vs. OA Three papers [1,13,64] compared the risk of
revision for aseptic loosening for patients with RA and
OA, and one paper found a statistically significant
increased risk for OA patients.
Surgical and implant-related factors
Uncemented vs. cemented fixation All six papers
[13,17,19,81-83] reporting on fixation found statisti-
cally significant associations with risk of revision
for aseptic loosening. Three papers found an in-
creased risk for fully uncemented prostheses and the
other three found an increased risk for cemented
prostheses.
Table 4 Comparison of risk factors for revision for all endpoints addressed by at least three studies
Risk factor Studies reporting on a risk factor for each endpoint: total number, number reporting a statistically
significant (p≤.05) increased (+) or decreased (—) risk of revision, and number with no significant
association (p>.05)
Revision (any) Aseptic loosening Infection Dislocation
Np ≤.05 p>.05 N p≤.05 p>.05 N p≤.05 p>.05 N p≤.05 p>.05
+ — + — + — + —
Demographic and Clinical Factors
Young age 26: 15 2 9 12: 804 5: 005 4: 02 2
Male sex 18: 711 0 10: 514 6: 501 —
Higher BMI/weight 5: 005 ———
Higher Charlson score 5: 500 ———
Underlying Diagnosis
RA (vs. OA) 9: 306 3: 012 6: 105 3: 10 2
AVN (vs. OA) 8: 512 — 3: 102 —
RA (vs. AVN) 4: 004 — 3: 003 —
DDH (vs. RA) —— — 3: — 03
Surgical and Implant-Related Factors
Uncemented (vs. cem) 10: 523 6: 330 4: 013 —
Hybrid (vs. cem) 4: 202 ———
Hybrid (vs. uncem) 4: 121 ———
Larger femoral head 3: 201 —— 3: 03 0
Uncem (vs. cem AL)* —— 3: 102 —
Cem NA (vs. uncem) —— 3: 300 —
Cem NA (vs. cem AL) —— 3: 300 —
Longer operating time —— 4: 301 —
Posterior surgical approach (vs. lateral) —— — 3: 20 1
Health Care Provider-Related Factors
Lower hospital volume 6: 105 ———
Lower surgeon volume 4: 301 ———
* Cem AL = antibiotic-loaded cement.
Cem NA = cement not containing antibiotics.
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Demographic and Clinical Factors
Sex Five of the six papers [13,43-46,54] that examined
sex as a risk factor for revision for infection found a sta-
tistically significant increased risk for men.
Underlying Diagnosis
RA vs. OA Six papers [13,43,44,46,54,61] compared the
risk of revision for infection for patients with RA and
OA (including two papers that compared OA and “in-
flammatory arthritis”), one of which found a statistically
significant increased risk for patients with RA.
AVN vs. OA Of the three papers [13,44,46] that com-
pared patients with AVN and OA for risk of revision
due to infection, one paper reported a significant
increased risk for AVN.
Surgical and Implant-Related Factors
Uncemented vs. cemented fixation Four papers [13,26,
81,83] reported on uncemented vs. cemented fixation as
a risk factor for revision due to infection. One paper
found a statistically significant increased risk for cemen-
ted fixation.
Uncemented vs. antibiotic-loaded cement Of the three
papers [43,46,81] that compared uncemented prostheses
with those containing antibiotic-loaded cement, one
found a statistically significant increased risk for unce-
mented prostheses.
Uncemented vs cement not containing antibiotics All
three papers [43,46,81] that compared revision risk due
to infection for uncemented prostheses vs. those with
cement not containing antibiotics found a statistically
significant increased risk for cement without antibiotics.
Antibiotic-loaded cement vs. cement not containing
antibiotics All three papers [43,46,81] that compared
the risk of revision for infection between prostheses
cemented with and without antibiotics found a statisti-
cally significant increased risk for cement not containing
antibiotics.
Operating time Of the four papers [43,45,46,83] that
examined operating time as a risk factor for revision due
to infection, three found a statistically significant
increased risk for longer surgeries.
Revision for dislocation
Demographic and Clinical Factors
Age Four papers [26,47-49] examined age at primary
THA as a risk factor for revision due to dislocation, two
of which found a statistically significant increased risk
for older age.
Underlying Diagnosis
RA vs. OA Of the three papers [47,48,61] that compared
the risk of revision for dislocation in patients with RA
and OA, one paper reported a significant increased risk
for patients with RA.
Surgical and Implant-Related Factors
Femoral head size All three papers [47-49] that exam-
ined femoral head size as a risk factor for revision due to
dislocation found a statistically significant increased risk
for smaller head size. In all three studies, head sizes
>28mm were associated with a lower risk than head
sizes ≤28mm.
Posterior vs lateral surgical approach Of the three
papers [11,26,48] that examined the risk of revision for
dislocation associated with the posterior vs. lateral surgi-
cal approach, two found a statistically significant
increased risk for the posterior approach. Of note, the
third study reported that the posterior approach was
associated with a “greater early risk of dislocation,” but
that the failure rates for the two approaches evened out
later on in the seven-year follow-up period [26].
Discussion
We conducted a systematic literature review on risk fac-
tors for revision of primary THA relating to the charac-
teristics of the patient, surgery, implant, and health care
provider. We focused on papers published since the year
2000 in order to provide the most up-to-date findings.
We present information on risk factors studied in at
least three papers for one of our endpoints of interest:
revision for any reason or for an indication of aseptic
loosening, infection, or dislocation.
The potential risk factors that were studied by at least
three papers for several endpoints were patient age and
sex, underlying diagnosis, and implant fixation (cemen-
ted vs. uncemented). Younger age at the time of primary
THA was generally associated with a higher risk of over-
all revision and revision for aseptic loosening, but
younger age was also associated with a lower risk of dis-
location. Male sex was generally associated with a higher
risk of revision for aseptic loosening and infection, and
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overall revision.
Our findings with regard to fixation were inconclusive.
Consistent with prior reviews, [6,9] we found a trend to-
ward an increased revision risk for fully uncemented
prostheses: often studies that examined fixation as a risk
factor for overall revision, five found a statistically sig-
nificant increased risk for uncemented prostheses, two
found a statistically significant increased risk for cemen-
ted prostheses, and three reported no significant associa-
tions. A review by Morshed et al. [9] suggests that the
performance of fully uncemented implants may be im-
proving over time as compared with cemented implants.
Our findings suggest the opposite: among papers
included in this review, the two that found an increased
risk for cemented implants examined primary THAs
implanted in the 1980s and early 1990s, while studies fo-
cusing on more recently implanted THAs found a
higher revision risk for fully uncemented implants. This
discrepancy may be due to the fact that nine of the 20
papers in the Morshed review were published prior to
2000 and were therefore excluded from our initial search
query. Many of the rest were ineligible for this review
because they had small sample sizes or examined failure
of a specific component rather than revision of any
component.
There were other notable findings concerning risk fac-
tors for specific endpoints as well. Greater comorbidity
and low surgeon volume were both associated with a
higher risk of overall revision, as was a diagnosis of AVN
as compared to OA. Longer operating time was asso-
ciated with a higher risk of revision for infection. Smaller
femoral head size was associated with an increased risk
for dislocation.
The results of this review indicate that factors may in-
crease the risk of revision for certain endpoints but be
protective for others. For example, younger age was gen-
erally associated with an increased risk of revision for
aseptic loosening and for overall revision, but seemed to
reduce the risk of dislocation. Similarly, smaller femoral
head size increased the risk of dislocation, but may also
be associated with a decreased risk of overall revision. In
cases where a given risk factor works in different direc-
tions for the specific indications, we might expect less
clarity and uniformity with regard to overall revision.
Several challenges and limitations of our review bear
comment and suggest avenues for further work. The
studies in our review examined revision surgery as an
endpoint, but revision rates do not capture failed
implants that are not surgically revised. Focusing on re-
vision misses patients with painful prostheses who do
not seek medical attention, who choose not to have revi-
sion, or who are not offered revision because their gen-
eral health makes them unsuitable surgical candidates.
Thus, revision is a specific but insensitive marker of
THA failure. Validation studies on the Swedish Register
have indicated that clinical failure rates at ten years, as
defined by radiographic loosening in combination with
the Harris Hip Score and the Western Ontario and
McMaster Osteoarthritis Index (WOMAC), are at least
twice as high as the revision rates reported by the Regis-
ter [3,94,95].
With the exception of case–control studies, we limited
our review to large studies with at least 2,500 person-
years of follow-up to enhance the generalizability of our
findings and the stability of the estimates from the
included studied. Eleven case–control studies were
included in the review, but only two reported on risk
factors that were included in Table 4. Approximately half
the papers included in our review were retrospective
analyses of data collected in population-based registries.
This may account for the relative paucity of studies
reporting on factors that are less commonly tracked in
registries, such as socioeconomic status, genetic factors,
functional status, and features of the operating room.
This observation underscores the value of comprehen-
sive arthroplasty registries for research purposes, above
and beyond their role in identifying prostheses or patient
populations with unusually high rates of failure or com-
plications [96,97].
In addition to the person-years exclusion of smaller
cohort studies or studies with shorter follow-up, our
results may have been influenced by publication bias
favoring statistically significant results. We are only able
to summarize the data that authors chose to include in
their published papers, and although some authors re-
port all the results of their analyses, others may choose
to report only those findings they consider most inter-
esting or relevant.
The use of statistical significance as a binary outcome
represents another potential limitation. Statistical signifi-
cance cut-offs are inherently arbitrary, and though they
can provide a useful guide for identifying consistent pat-
terns, they are directly tied to sample size and duration
of follow-up [98]. Table 4 allows us to see risk factors
with a clear signal across papers, but without also con-
sidering the range of reported effect sizes, we cannot de-
termine if the increased or decreased risk is clinically
meaningful.
Due to the large number and variety of papers and po-
tential risk factors examined in this review, we were un-
able to score each study for methodological quality,
contrast design features, or compare quantitative results.
Listing a tally of positive, negative, and non-statistically
significant associations is “rough justice” with respect to
any particular factor, but it can serve as a guide to the
overall state of research on revision of THA. This review
provides a comprehensive picture of what has and has
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 9 of 13
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sense of whether the findings have been concordant
across studies. Researchers may find it helpful to see
what has already been done, and where there are oppor-
tunities for further work to deepen or clarify our under-
standing of certain issues.
Finally, we call attention to the importance of adjust-
ing for potential confounders. In some of the studies in
this review, the unadjusted and adjusted results for cer-
tain risk factors produced statistically significant associa-
tions in opposite directions due the presence of
confounding factors [13]. For example, patients with
high BMI undergoing THA tend to be younger than the
average patient, so a failure to adjust for the effect of
young age could result in an inflated risk estimate for
BMI. In this review, we abstracted and reported adjusted
results whenever possible. Many papers provided only
unadjusted results, however, and we were unable to ad-
just for confounders when calculating risk ratios from
raw data.
Conclusions
In this review, factors found to be consistently associated
with revision included younger age, greater comorbidity,
a diagnosis of AVN as compared to OA, low surgeon
volume, and larger femoral head size. Male sex was asso-
ciated with revision due to aseptic loosening and infec-
tion. Longer operating time was associated with revision
due to infection. Smaller femoral head size was asso-
ciated with revision due to dislocation.
These findings may be useful to surgeons and patients
contemplating THA or living with THA as they discuss
the scientific evidence for potential risk factors for revi-
sion. Some important factors, such as prosthesis materi-
als and design, were not addressed by a sufficient
number of papers that met our criteria to be included in
this review, and the results for factors like fixation did
not produce a clear signal. Further research could clarify
the prognostic effect of these factors. We also need more
work to determine the level of agreement between risk
factors for revision of primary THA, as identified in this
review, and risk factors for failure of primary THA, a
more pertinent outcome for patients, but one that is
much more difficult to study.
Abbreviations
AVN: Avascular necrosis; DDH: Developmental dysplasia of the hip;
OA: Osteoarthritis; RA: Rheumatoid arthritis; THA: Total hip arthroplasty;
WOMAC: Western Ontario and McMaster Osteoarthritis Index.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JJZP, EL, and JNK conceived and designed the review. JJZP performed the
search, screening, and abstraction, and JNK provided validation (see
Validation in Methods). RLB performed the data analysis. All authors were
involved in drafting and revising the manuscript, and all gave approval of
the final version.
Grant support
NIH/NIAMS P60 AR 47782, K24 AR 057827, T32 AR 055885
Acknowledgements
This work was funded by the National Institutes of Health (NIH)/National
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NIH and
NIAMS played no role in this study beyond providing funding.
Author details
1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
2Harvard Medical School, Boston, MA, USA.
3Boston University School of
Public Health, Boston, MA, USA.
4Veristat, Inc., Holliston, MA, USA.
5University
of North Carolina, Chapel HillNC, USA.
6Harvard School of Public Health,
Boston, MA, USA.
7Orthopedic and Arthritis Center for Outcomes Research,
Brigham and Women’s Hospital, 75 Francis St. OBC-4, Boston, MA 02115,
USA.
Received: 26 April 2012 Accepted: 5 December 2012
Published: 15 December 2012
References
1. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF: Twenty-five-year
survivorship of two thousand consecutive primary Charnley total hip
replacements: factors affecting survivorship of acetabular and femoral
components. J Bone Joint Surg Am 2002, 84-A(2):171–177.
2. Soderman P, Malchau H, Herberts P: Outcome after total hip arthroplasty:
Part I. General health evaluation in relation to definition of failure in the
Swedish National Total Hip Arthoplasty register. Acta Orthop Scand 2000,
71(4):354–359.
3. Soderman P, Malchau H, Herberts P, Zugner R, Regner H, Garellick G:
Outcome after total hip arthroplasty: Part II. Disease-specific follow-up
and the Swedish National Total Hip Arthroplasty Register. Acta Orthop
Scand 2001, 72(2):113–119.
4. HCUPnet, Healthcare Cost and Utilization Project: Agency for Healthcare
Research and Quality, Rockville, MD (2009). United States Department of
Health & Human Services 2009, http://hcupnet.ahrq.gov/.
5. Ong KL, Mowat FS, Chan N, Lau E, Halpern MT, Kurtz SM: Economic burden
of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop
Relat Res 2006, 446:22–28.
6. Corbett KL, Losina E, Nti AA, Prokopetz JJ, Katz JN: Population-based rates
of revision of primary total hip arthroplasty: a systematic review.
PLoS One 2010, 5(10):e13520.
7. Macfarlane AJ, Prasad GA, Chan VW, Brull R: Does regional anaesthesia
improve outcome after total hip arthroplasty? A systematic review.
Br J Anaesth 2009, 103(3):335–345.
8. Johannson HR, Zywiel MG, Marker DR, Jones LC, McGrath MS, Mont MA:
Osteonecrosis is not a predictor of poor outcomes in primary total hip
arthroplasty: a systematic literature review. Int Orthop 2010,
35(4):465–473.
9. Morshed S, Bozic KJ, Ries MD, Malchau H, Colford JM Jr: Comparison of
cemented and uncemented fixation in total hip replacement: a meta-
analysis. Acta Orthop 2007, 78(3):315–326.
10. Santaguida PL, Hawker GA, Hudak PL, Glazier R, Mahomed NN, Kreder HJ,
Coyte PC, Wright JG: Patient characteristics affecting the prognosis of
total hip and knee joint arthroplasty: a systematic review. Can J Surg
2008, 51(6):428–436.
11. Arthursson AJ, Furnes O, Espehaug B, Havelin LI, Soreide JA: Prosthesis
survival after total hip arthroplasty–does surgical approach matter?
Analysis of 19,304 Charnley and 6,002 Exeter primary total hip
arthroplasties reported to the Norwegian Arthroplasty Register.
Acta Orthop 2007, 78(6):719–729.
12. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ: The epidemiology of
revision total hip arthroplasty in the United States. J Bone Joint Surg Am
2009, 91(1):128–133.
13. Hailer NP, Garellick G, Karrholm J: Uncemented and cemented primary
total hip arthroplasty in the Swedish Hip Arthroplasty Register.
Acta Orthop 2010, 81(1):34–41.
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 10 of 13
http://www.biomedcentral.com/1471-2474/13/25114. Lai YS, Wei HW, Cheng CK: Incidence of hip replacement among national
health insurance enrollees in Taiwan. J Orthop Surg Res 2008, 3:42.
15. Agabiti N, Picciotto S, Cesaroni G, Bisanti L, Forastiere F, Onorati R, Pacelli B,
Pandolfi P, Russo A, Spadea T, et al: The influence of socioeconomic status
on utilization and outcomes of elective total hip replacement: a
multicity population-based longitudinal study. Int J Qual Health Care 2007,
19(1):37–44.
16. Callaghan JJ, Liu SS, Firestone DE, Yehyawi TM, Goetz DD, Sullivan J, Vittetoe
DA, O'Rourke MR, Johnston RC: Total hip arthroplasty with cement and
use of a collared matte-finish femoral component: nineteen to twenty-
year follow-up. J Bone Joint Surg Am 2008, 90(2):299–306.
17. Corten K, Bourne RB, Charron KD, Au K, Rorabeck CH: What works best, a
cemented or cementless primary total hip arthroplasty?: minimum 17-
year followup of a randomized controlled trial. Clin Orthop Relat Res 2011,
469(1):209–217.
18. El Masri F, Kerboull L, Kerboull M, Courpied JP, Hamadouche M: Is the so-
called 'French paradox' a reality?: long-term survival and migration of
the Charnley-Kerboull stem cemented line-to-line. J Bone Joint Surg Br
2010, 92(3):342–348.
19. Eskelinen A, Paavolainen P, Helenius I, Pulkkinen P, Remes V: Total hip
arthroplasty for rheumatoid arthritis in younger patients: 2,557
replacements in the Finnish Arthroplasty Register followed for
0–24 years. Acta Orthop 2006, 77(6):853–865.
20. Eskelinen A, Remes V, Helenius I, Pulkkinen P, Nevalainen J, Paavolainen P:
Total hip arthroplasty for primary osteoarthrosis in younger patients in
the Finnish arthroplasty register. 4,661 primary replacements followed
for 0–22 years. Acta Orthop 2005, 76(1):28–41.
21. Fender D, van der Meulen JH, Gregg PJ: Relationship between outcome
and annual surgical experience for the charnley total hip replacement.
Results from a regional hip register. J Bone Joint Surg Br 2003,
85(2):187–190.
22. Franklin J, Robertsson O, Gestsson J, Lohmander LS, Ingvarsson T: Revision
and complication rates in 654 Exeter total hip replacements, with a
maximum follow-up of 20 years. BMC Musculoskelet Disord 2003, 4:6.
23. Gillam MH, Ryan P, Graves SE, Miller LN, de Steiger RN, Salter A: Competing
risks survival analysis applied to data from the Australian Orthopaedic
Association National Joint Replacement Registry. Acta Orthop 2010,
81(5):548–555.
24. Hartofilakidis G, Karachalios T, Karachalios G: The 20-year outcome of the
charnley arthroplasty in younger and older patients. Clin Orthop Relat Res
2005, 434:177–182.
25. Havelin LI, Fenstad AM, Salomonsson R, Mehnert F, Furnes O, Overgaard S,
Pedersen AB, Herberts P, Karrholm J, Garellick G: The Nordic Arthroplasty
Register Association: a unique collaboration between 3 national hip
arthroplasty registries with 280,201 THRs. Acta Orthop 2009,
80(4):393–401.
26. Hooper GJ, Rothwell AG, Stringer M, Frampton C: Revision following
cemented and uncemented primary total hip replacement: a seven-year
analysis from the New Zealand Joint Registry. J Bone Joint Surg Br 2009,
91(4):451–458.
27. Johnsen SP, Sorensen HT, Lucht U, Soballe K, Overgaard S, Pedersen AB:
Patient-related predictors of implant failure after primary total hip
replacement in the initial, short- and long-terms. A nationwide Danish
follow-up study including 36,984 patients. J Bone Joint Surg Br 2006,
88(10):1303–1308.
28. Kerboull L, Hamadouche M, Courpied JP, Kerboull M: Long-term results of
Charnley-Kerboull hip arthroplasty in patients younger than 50 years.
Clin Orthop Relat Res 2004, 418:112–118.
29. Losina E, Barrett J, Mahomed NN, Baron JA, Katz JN: Early failures of total
hip replacement: effect of surgeon volume. Arthritis Rheum 2004,
50(4):1338–1343.
30. McAuley JP, Szuszczewicz ES, Young A, Engh CA Sr: Total hip arthroplasty
in patients 50 years and younger. Clin Orthop Relat Res 2004, 418:119–125.
31. Mullins MM, Norbury W, Dowell JK, Heywood-Waddington M: Thirty-year
results of a prospective study of Charnley total hip arthroplasty by the
posterior approach. J Arthroplasty 2007, 22(6):833–839.
32. Older J: Charnley low-friction arthroplasty: a worldwide retrospective
review at 15 to 20 years. J Arthroplasty 2002, 17(6):675–680.
33. Ong KL, Lau E, Manley M, Kurtz SM: Effect of procedure duration on total
hip arthroplasty and total knee arthroplasty survivorship in the United
States Medicare population. J Arthroplasty 2008, 23(6 Suppl 1):127–132.
34. Ong KL, Lau E, Suggs J, Kurtz SM, Manley MT: Risk of subsequent revision
after primary and revision total joint arthroplasty. Clin Orthop Relat Res
2010, 468(11):3070–3076.
35. Paterson JM, Williams JI, Kreder HJ, Mahomed NN, Gunraj N, Wang X,
Laupacis A: Provider volumes and early outcomes of primary total joint
replacement in Ontario. Can J Surg 2010, 53(3):175–183.
36. Puolakka TJ, Pajamaki KJ, Halonen PJ, Pulkkinen PO, Paavolainen P,
Nevalainen JK: The Finnish Arthroplasty Register: report of the hip
register. Acta Orthop Scand 2001, 72(5):433–441.
37. Stea S, Bordini B, De Clerico M, Petropulacos K, Toni A: First hip
arthroplasty register in Italy: 55,000 cases and 7 year follow-up. Int
Orthop 2009, 33(2):339–346.
38. Hallan G, Lie SA, Furnes O, Engesaeter LB, Vollset SE, Havelin LI:
Medium- and long-term performance of 11,516 uncemented primary
femoral stems from the Norwegian arthroplasty register. J Bone Joint Surg
Br 2007, 89(12):1574–1580.
39. Poon PC, Rennie J, Gray DH: Review of total hip replacement. The
Middlemore Hospital experience, 1980–1991. N Z Med J 2001,
114(1133):254–256.
40. Satoh M, Kawaguchi T, Masuhara K: Risk factors for revision total hip
arthroplasty: emphasis on the characteristics of Japanese lifestyle. Arch
Orthop Trauma Surg 2009, 129(12):1707–1713.
41. Tarasevicius S, Kesteris U, Robertsson O, Smailys A, Janusonis V, Wingstrand
H: Introduction of total hip arthroplasty in Lithuania: results from the
first 10 years. Acta Orthop 2007, 78(4):454–457.
42. Tarasevicius S, Kesteris U, Robertsson O, Wingstrand H: Femoral head
diameter affects the revision rate in total hip arthroplasty: an analysis of
1,720 hip replacements with 9–21 years of follow-up. Acta Orthop 2006,
77(5):706–709.
43. Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB: Increasing risk of
revision due to deep infection after hip arthroplasty. Acta Orthop 2009,
80(6):639–645.
44. Hamilton H, Jamieson J: Deep infection in total hip arthroplasty.
Can J Surg 2008, 51(2):111–117.
45. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J: Prosthetic joint
infection risk after total hip arthroplasty in the Medicare population.
J Arthroplasty 2009, 24(6 Suppl):105–109.
46. Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S: Risk factors for
revision due to infection after primary total hip arthroplasty. A
population-based study of 80,756 primary procedures in the Danish Hip
Arthroplasty Registry. Acta Orthop 2010, 81(5):542–547.
47. Conroy JL, Whitehouse SL, Graves SE, Pratt NL, Ryan P, Crawford RW:
Risk factors for revision for early dislocation in total hip arthroplasty.
J Arthroplasty 2008, 23(6):867–872.
48. Bystrom S, Espehaug B, Furnes O, Havelin LI: Femoral head size is a risk
factor for total hip luxation: a study of 42,987 primary hip arthroplasties
from the Norwegian Arthroplasty Register. Acta Orthop Scand 2003,
74(5):514–524.
49. Sexton SA, Walter WL, Jackson MP, De Steiger R, Stanford T: Ceramic-on-
ceramic bearing surface and risk of revision due to dislocation after
primary total hip replacement. J Bone Joint Surg Br 2009,
91(11):1448–1453.
50. Kawamura H, Dunbar MJ, Murray P, Bourne RB, Rorabeck CH: The porous
coated anatomic total hip replacement. A ten to fourteen-year follow-up
study of a cementless total hip arthroplasty. J Bone Joint Surg Am 2001,
83-A(9):1333–1338.
51. Kearns SR, Jamal B, Rorabeck CH, Bourne RB: Factors affecting survival of
uncemented total hip arthroplasty in patients 50 years or younger. Clin
Orthop Relat Res 2006, 453:103–109.
52. Ogino D, Kawaji H, Konttinen L, Lehto M, Rantanen P, Malmivaara A,
Konttinen YT, Salo J: Total hip replacement in patients eighty years of
age and older. J Bone Joint Surg Am 2008, 90(9):1884–1890.
53. Ong A, Wong KL, Lai M, Garino JP, Steinberg ME: Early failure of precoated
femoral components in primary total hip arthroplasty. J Bone Joint Surg
Am 2002, 84-A(5):786–792.
54. Schrama JC, Espehaug B, Hallan G, Engesaeter LB, Furnes O, Havelin LI,
Fevang BT: Risk of revision for infection in primary total hip and knee
arthroplasty in patients with rheumatoid arthritis compared with
osteoarthritis: a prospective, population-based study on 108,786 hip and
knee joint arthroplasties from the Norwegian Arthroplasty Register.
Arthritis Care Res (Hoboken) 2010, 62(4):473–479.
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 11 of 13
http://www.biomedcentral.com/1471-2474/13/25155. Haverkamp D, de Man FH, de Jong PT, van Stralen RA, Marti RK: Is the long-
term outcome of cemented THA jeopardized by patients being
overweight? Clin Orthop Relat Res 2008, 466(5):1162–1168.
56. Jackson MP, Sexton SA, Yeung E, Walter WL, Walter WK, Zicat BA: The effect
of obesity on the mid-term survival and clinical outcome of cementless
total hip replacement. J Bone Joint Surg Br 2009, 91(10):1296–1300.
57. Lubbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P: Differences in
outcomes of obese women and men undergoing primary total hip
arthroplasty. Arthritis Rheum 2007, 57(2):327–334.
58. Wendelboe AM, Hegmann KT, Biggs JJ, Cox CM, Portmann AJ, Gildea JH,
Gren LH, Lyon JL: Relationships between body mass indices and surgical
replacements of knee and hip joints. Am J Prev Med 2003, 25(4):290–295.
59. Yeung E, Jackson M, Sexton S, Walter W, Zicat B: The effect of obesity on
the outcome of hip and knee arthroplasty. Int Orthop 2011, 35(6):929–934.
60. Malik MH, Gray J, Kay PR: Early aseptic loosening of cemented total hip
arthroplasty: the influence of non-steroidal anti-inflammatory drugs and
smoking. Int Orthop 2004, 28(4):211–213.
61. Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI: Hip
disease and the prognosis of total hip replacements. A review of 53,698
primary total hip replacements reported to the Norwegian Arthroplasty
Register 1987–99. J Bone Joint Surg Br 2001, 83(4):579–586.
62. Rud-Sorensen C, Pedersen AB, Johnsen SP, Riis AH, Overgaard S: Survival of
primary total hip arthroplasty in rheumatoid arthritis patients.
Acta Orthop 2010, 81(1):60–65.
63. van der Lugt JC, Onstenk R, Nelissen RG: Primary Stanmore total hip
arthroplasty with increased cup loosening in rheumatoid patients.
Int Orthop 2003, 27(5):291–293.
64. Zwartele R, Peters A, Brouwers J, Olsthoorn P, Brand R, Doets C: Long-term
results of cementless primary total hip arthroplasty with a threaded cup
and a tapered, rectangular titanium stem in rheumatoid arthritis and
osteoarthritis. Int Orthop 2008, 32(5):581–587.
65. Steinberg ME, Lai M, Garino JP, Ong A, Wong KL: A comparison between
total hip replacement for osteonecrosis and degenerative joint disease.
Orthopedics 2008, 31(4):360.
66. Hartofilakidis G, Karachalios T: Total hip arthroplasty for congenital hip
disease. J Bone Joint Surg Am 2004, 86-A(2):242–250.
67. Thillemann TM, Pedersen AB, Johnsen SP, Soballe K: Implant survival after
primary total hip arthroplasty due to childhood hip disorders: results
from the Danish Hip Arthroplasty Registry. Acta Orthop 2008,
79(6):769–776.
68. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K:
Postoperative use of bisphosphonates and risk of revision after primary
total hip arthroplasty: a nationwide population-based study. Bone 2010,
46(4):946–951.
69. Veitch SW, Whitehouse SL, Howell JR, Hubble MJ, Gie GA, Timperley AJ: The
concentric all-polyethylene Exeter acetabular component in primary
total hip replacement. J Bone Joint Surg Br 2010, 92(10):1351–1355.
70. Pedersen AB, Mehnert F, Johnsen SP, Sorensen HT: Risk of revision of a
total hip replacement in patients with diabetes mellitus: a population-
based follow up study. J Bone Joint Surg Br 2010, 92(7):929–934.
71. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K: Use of
diuretics and risk of implant failure after primary total hip arthroplasty: a
nationwide population-based study. Bone 2009, 45(3):499–504.
72. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K: The risk of
revision after primary total hip arthroplasty among statin users: a
nationwide population-based nested case–control study. J Bone Joint
Surg Am 2010, 92(5):1063–1072.
73. Berend ME, Ritter MA, Harty LD, Davis KE, Keating EM, Meding JB, Thong AE:
Simultaneous bilateral versus unilateral total hip arthroplasty an
outcomes analysis. J Arthroplasty 2005, 20(4):421–426.
74. Kim YH, Kwon OR, Kim JS: Is one-stage bilateral sequential total hip
replacement as safe as unilateral total hip replacement? J Bone Joint Surg
Br 2009, 91(3):316–320.
75. Lie SA, Engesaeter LB, Havelin LI, Gjessing HK, Vollset SE: Dependency
issues in survival analyses of 55,782 primary hip replacements from
47,355 patients. Stat Med 2004, 23(20):3227–3240.
76. Lunn JV, Gallagher PM, Hegarty S, Kaliszer M, Crowe J, Murray P, Bouchier-
Hayes D: The role of hereditary hemochromatosis in aseptic loosening
following primary total hip arthroplasty. J Orthop Res 2005,
23(3):542–548.
77. Malik MH, Bayat A, Jury F, Ollier WE, Kay PR: Genetic susceptibility to hip
arthroplasty failure–association with the RANK/OPG pathway. Int Orthop
2006, 30(3):177–181.
78. Malik MH, Jury F, Bayat A, Ollier WE, Kay PR: Genetic susceptibility to total
hip arthroplasty failure: a preliminary study on the influence of matrix
metalloproteinase 1, interleukin 6 polymorphisms and vitamin D
receptor. Ann Rheum Dis 2007, 66(8):1116–1120.
79. Sierra RJ, Trousdale RT, Cabanela ME: Pregnancy and childbirth after total
hip arthroplasty. J Bone Joint Surg Br 2005, 87(1):21–24.
80. Chandran P, Azzabi M, Miles J, Andrews M, Bradley J: Furlong
hydroxyapatite-coated hip prosthesis vs the Charnley cemented hip
prosthesis. J Arthroplasty 2010, 25(1):52–57.
81. Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI: Does cement
increase the risk of infection in primary total hip arthroplasty? Revision
rates in 56,275 cemented and uncemented primary THAs followed for
0–16 years in the Norwegian Arthroplasty Register. Acta Orthop 2006,
77(3):351–358.
82. Makela KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V: Total hip
arthroplasty for primary osteoarthritis in patients fifty-five years of age
or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg
Am 2008, 90(10):2160–2170.
83. Smabrekke A, Espehaug B, Havelin LI, Furnes O: Operating time and
survival of primary total hip replacements: an analysis of 31,745 primary
cemented and uncemented total hip replacements from local hospitals
reported to the Norwegian Arthroplasty Register 1987–2001. Acta Orthop
Scand 2004, 75(5):524–532.
84. Kawanabe K, Tanaka K, Tamura J, Shimizu M, Onishi E, Iida H, Nakamura T:
Effect of alumina femoral head on clinical results in cemented total hip
arthroplasty: old versus current alumina. J Orthop Sci 2005, 10(4):378–384.
85. Bozic KJ, Ong K, Lau E, Kurtz SM, Vail TP, Rubash HE, Berry DJ: Risk of
complication and revision total hip arthroplasty among Medicare
patients with different bearing surfaces. Clin Orthop Relat Res 2010,
468(9):2357–2362.
86. Naudie D, Roeder CP, Parvizi J, Berry DJ, Eggli S, Busato A: Metal-on-metal
versus metal-on-polyethylene bearings in total hip arthroplasty: a
matched case–control study. J Arthroplasty 2004, 19(7 Suppl 2):35–41.
87. Altenburg AJ, Callaghan JJ, Yehyawi TM, Pedersen DR, Liu SS, Leinen JA,
Dahl KA, Goetz DD, Brown TD, Johnston RC: Cemented total hip
replacement cable debris and acetabular construct durability. J Bone
Joint Surg Am 2009, 91(7):1664–1670.
88. de Jong PT, van der Vis HM, de Man FH, Marti RK: Weber rotation total hip
replacement: a prospective 5- to 20-year followup study. Clin Orthop
Relat Res 2004, 419:107–114.
89. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI:
Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic
prophylaxis systemically and in bone cement on the revision rate of
22,170 primary hip replacements followed 0–14 years in the Norwegian
Arthroplasty Register. Acta Orthop Scand 2003, 74(6):644–651.
90. Klapach AS, Callaghan JJ, Goetz DD, Olejniczak JP, Johnston RC: Charnley
total hip arthroplasty with use of improved cementing techniques: a
minimum twenty-year follow-up study. J Bone Joint Surg Am 2001,
83-A(12):1840–1848.
91. Judge A, Chard J, Learmonth I, Dieppe P: The effects of surgical volumes
and training centre status on outcomes following total joint
replacement: analysis of the Hospital Episode Statistics for England.
J Public Health (Oxf) 2006, 28(2):116–124.
92. Manley M, Ong K, Lau E, Kurtz SM: Effect of volume on total hip
arthroplasty revision rates in the United States Medicare population.
J Bone Joint Surg Am 2008, 90(11):2446–2451.
93. Palan J, Gulati A, Andrew JG, Murray DW, Beard DJ: The trainer, the trainee
and the surgeons' assistant: clinical outcomes following total hip
replacement. J Bone Joint Surg Br 2009, 91(7):928–934.
94. Herberts P, Malchau H: Long-term registration has improved the quality
of hip replacement: a review of the Swedish THR Register comparing
160,000 cases. Acta Orthop Scand 2000, 71(2):111–121.
95. Soderman P: On the validity of the results from the Swedish National
Total Hip Arthroplasty register. Acta Orthop Scand Suppl 2000,
71(296):1–33.
96. Maloney WJ: National Joint Replacement Registries: has the time come?
J Bone Joint Surg Am 2001, 83-A(10):1582–1585.
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 12 of 13
http://www.biomedcentral.com/1471-2474/13/25197. von Knoch F, Malchau H: Why do we need a national joint replacement
registry in the United States? Am J Orthop (Belle Mead NJ) 2009,
38(10):500–503.
98. Gelman A, Stern H: The Difference Between “Significant” and “Not
Significant” is not Itself Statistically Significant. Am Stat 2006,
60(4):328–331.
doi:10.1186/1471-2474-13-251
Cite this article as: Prokopetz et al.: Risk factors for revision of primary
total hip arthroplasty: a systematic review. BMC Musculoskeletal Disorders
2012 13:251.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 13 of 13
http://www.biomedcentral.com/1471-2474/13/251